Tempus AI: First Positive EBITDA, Huge TAM - Yet The Stock Isn't A Buy

Group 1 - Tempus AI is an AI company focused on healthcare, boasting one of the largest clinical and genomic datasets in the US [1] - The company presents an exciting investment thesis due to its unique position in the healthcare AI market [1] Group 2 - The article does not provide specific financial metrics or performance data related to Tempus AI [2]